All news on the topic: Michael Leuchten

440
AstraZeneca explores takeover of Bristol Myers Squibb in potential $400bn deal
Britain’s biggest drugmaker, AstraZeneca, is understood to be in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group.